Obesity-Linked Gaps in Pulmonary Embolism Management – Shared by Zain Khalpey
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, posted on LinkedIn:
”Obesity changes everything about pulmonary embolism from diagnosis to drug dosing.
This new JACC review highlights how body size complicates imaging accuracy, influences anticoagulant and interventional choices, and even shapes outcomes through the “obesity paradox.”
The takeaway is clear: one size fits all guidance doesn’t work.
We need pragmatic, obesity-aware protocols and updated guidelines that reflect real world patients.
Full review here.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps
Authors: Marco Zuin, Gregory Piazza, Stefano Barco, Laurent Bertoletti, Michal Ciurzynski, Nika Skoro-Sajer, Marcin Kurzyna, Sophia Anastasia Mouratoglou, Lukas Hobohm, Frederikus A. Klok
Keep up with Hemostasis Today.
-
Feb 21, 2026, 15:58Addressing Underdiagnosis and Care Inequities in Women and Girls with Bleeding Disorders – WFH
-
Feb 21, 2026, 15:49Sheharyar Raza: The Leaky Pipeline of AI and Machine Learning in Transfusion Medicine
-
Feb 21, 2026, 15:21Joanna Sadowska: Watching a Stem Cell Divide Reveals Life’s Blueprint
-
Feb 21, 2026, 14:43Gashaw Arega: Demonstrating Impact Through Blood Donation for Childhood Cancer
-
Feb 21, 2026, 14:42Travel Tips for Attending WFH 2026 World Congress in Kuala Lumpur
-
Feb 21, 2026, 13:56Tagreed Alkaltham: Transfusion Misidentification – When Identity Errors Become Fatal
-
Feb 21, 2026, 13:46Timothy Stalker: Differences Between Arterial and Venous Hemostasis
-
Feb 21, 2026, 13:36Augustina Isioma Ikusemoro: Strengthening Awareness and Prevention on World Anaemia Awareness Day
-
Feb 21, 2026, 13:20Mary Cushman: Novel Proteins Shed Light on the Mechanisms of VTE